Cell Source, Inc.
CLCS
$0.25
-$0.02-7.41%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.42M | -1.49M | -1.28M | -1.05M | -1.34M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 148.10K | 69.60K | 6.00K | 18.90K | 80.70K |
| Total Other Non-Cash Items | 221.10K | 16.70K | 208.80K | -17.50K | 73.50K |
| Change in Net Operating Assets | 408.90K | 279.50K | 886.80K | 326.20K | 904.00K |
| Cash from Operations | -639.00K | -1.12M | -173.90K | -722.30K | -280.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 159.40K | 500.00K | 146.70K | 30.00K | 452.00K |
| Total Debt Repaid | -28.50K | -12.50K | -20.00K | -88.00K | -191.50K |
| Issuance of Common Stock | 415.60K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 25.00K | 726.00K | 25.00K | 799.90K | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 571.50K | 1.21M | 151.70K | 741.90K | 260.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.60K | 90.50K | -22.20K | 19.60K | -19.40K |